back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-12 17:06 Tx date 2025-06-10 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
140,000 | |
| Filed 2025-04-14 15:44 Tx date 2025-04-07 |
$ACOG
Alpha Cognition Inc. |
Wills, Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,575 vol |
35,575 | |
| Filed 2025-04-14 15:43 Tx date 2025-04-07 |
$ACOG
Alpha Cognition Inc. |
Wills, Robert
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-08-29 16:53 Tx date 2024-08-28 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
100,000 | |
| Filed 2023-06-12 17:17 Tx date 2023-06-07 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
60,000 | |
| Filed 2022-10-19 16:21 Tx date 2022-10-19 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$73,918
+15,000 vol $4.93 each |
15,000 | |
| Filed 2022-10-19 16:19 Tx date 2020-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-10-02 17:20 Tx date 2020-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
30,000 | |
| Filed 2020-10-02 17:20 Tx date 2020-10-01 |
$MIST
Milestone Pharmaceuticals Inc. |
Wills, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|